Key result
Platelet proteomics and signaling mapping identify novel therapeutic targets and biomarkers in vascular disease.
Why the study?
Qualitatively distinguishable platelet phenotypes are increasingly associated with various conditions, but the origins and significance of platelet phenotypic variation remain unclear and conceptually vague.
Mapping platelet phosphoproteomic profiles onto causal intracellular signaling pathways offers a framework to molecularly define platelet phenotypes as circulating biomarkers and therapeutic targets in vascular and inflammatory diseases.
Answers are grounded in this paper and cite their sources.
May support platelet proteomics for identifying druggable targets in vascular disease; leaves open prospective validation before clinical adoption.
Platelets rapidly undergo responsive transitions in form and function to repair vascular endothelium and mediate hemostasis. In contrast, heterogeneous platelet subpopulations with a range of primed or refractory phenotypes gradually arise in chronic inflammatory and other conditions in a manner that may indicate or support disease. Qualitatively distinguishable platelet phenotypes are increasingly associated with a variety of physiological and pathological circumstances; however, the origins and significance of platelet phenotypic variation remain unclear and conceptually vague. As changes in platelet function in disease exhibit many similarities to platelets following the activation of platelet agonist receptors, the intracellular responses of platelets common to hemostasis and inflammation may provide insights to the molecular basis of platelet phenotype. Here, we review concepts around how protein-level relations-from platelet receptors through intracellular signaling events-may help to define platelet phenotypes in inflammation, immune responses, aging, and other conditions. We further discuss how representing systems-wide platelet proteomics data profiles as circuit-like networks of causally related intracellular events, or, pathway maps, may inform molecular definitions of platelet phenotype. In addition to offering insights into platelets as druggable targets, maps of causally arranged intracellular relations underlying platelet function can also advance precision and interceptive medicine efforts by leveraging platelets as accessible, dynamic, endogenous, circulating biomarkers of vascular wellness and disease. Graphic Abstract: A graphic abstract is available for this article.
No takes yet. Share an insight, caveat, or question.
Joseph E. Aslan (2021) conducted a review in Vascular disease and chronic inflammatory conditions involving platelet phenotypic variation. Platelet proteomics, phosphoproteomics, and causal pathway mapping was evaluated. Platelet proteomics and causal pathway mapping of intracellular signaling events can define heterogeneous platelet phenotypes as druggable targets and biomarkers in vascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: